​

Boundless Bio (BOLD) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Boundless Bio Revenue Highlights

00

Boundless Bio Revenue by Period

Boundless Bio Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31--

Boundless Bio generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Boundless Bio Revenue by Quarter

DateRevenueChange
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$1.06M100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30--

Boundless Bio generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Boundless Bio Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CASICASI Pharmaceuticals$33.88M$3.41M
SONNSonnet BioTherapeutics$147.81K-
ITRMIterum Therapeutics--
ENTOEntero Therapeutics--
BOLDBoundless Bio--
KZRKezar Life Sciences--
LPTXLeap Therapeutics--
CVKDCadrenal Therapeutics--
ANVSAnnovis Bio--
TAOXTAO Synergies--

BOLD Revenue FAQ

What is Boundless Bio’s yearly revenue?

Boundless Bio's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. BOLD's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Boundless Bio’s quarterly revenue?

Boundless Bio's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). BOLD's quarterly revenue for Q4 2024 was $1.06M, a 100.00% increase from the previous quarter (Q3 2024), and a 0% increase year-over-year (Q4 2023).

What is Boundless Bio’s revenue growth rate?

Boundless Bio's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2018-2024) was 0%.